Daniel D. Burton

This profile gathers the share dealings of Daniel D. Burton in Health Catalyst, Inc., where the filings describe the role as chief executive. The record holds 32 filings, for trades running from 1 June 2021 to 1 December 2025.

Purchases make up the whole of the open-market record (5 purchases, €5.6M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 22 share grants and 5 option exercises.

A typical purchase (the median) is worth €996k. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 3 December 2025 with a share grant (€139k) in Health Catalyst, Inc. The most recent open-market purchase was published on 27 February 2024, 964 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.